SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-114504
Filing Date
2021-04-13
Accepted
2021-04-13 14:56:59
Documents
8
Period of Report
2021-04-13

Document Format Files

Seq Description Document Type Size
1 6-K d50350d6k.htm 6-K 14271
2 EX-99.1 d50350dex991.htm EX-99.1 18385
3 EX-99.2 d50350dex992.htm EX-99.2 14785
4 EX-99.3 d50350dex993.htm EX-99.3 23975
5 EX-99.4 d50350dex994.htm EX-99.4 22133
6 GRAPHIC g50350g0413155449912.jpg GRAPHIC 2535
7 GRAPHIC g50350g0413155525769.jpg GRAPHIC 2535
8 GRAPHIC g50350g0413160517813.jpg GRAPHIC 2535
  Complete submission text file 0001193125-21-114504.txt   105630
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 21822891
SIC: 2834 Pharmaceutical Preparations